
Drug Development for Inflammatory Diseases Comes of Age
Gregory S. Moss, Esq., Chief Corporate Strategy and Legal Officer at Evommune, a company advancing therapies for chronic inflammatory diseases, shares his insights on these life-threatening conditions.